Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05373719 · ClinicalTrials.gov registry record
Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder
A clinical trial of Cyclin-Dependent Kinase-Like 5 Deficiency Disorder, sponsored by Loulou Foundation.
- Active
- Registry status
- 112
- Enrollment target
- 20
- Study locations
NCT05373719 is a study of Cyclin-Dependent Kinase-Like 5 Deficiency Disorder that is active but no longer recruiting, run by Loulou Foundation. The registered enrollment target is 112 participants. The trial reports 20 study locations across 9 states.
The verdict
NCT05373719, a study of Cyclin-Dependent Kinase-Like 5 Deficiency Disorder, is active but no longer recruiting, sponsored by Loulou Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- 112 participants
- Enrollment target
- 20
- Study locations
Study Summary
Observational, noninterventional, 3-year study to examine the presence of detectable differences in neurocognitive, developmental, motor, neurophysiologic, and quality of life measures over time in patients with cyclin-dependent kinase-like 5 deficiency disorder.
Conditions Studied
Interventions
- OTHER No intervention; observational
Study Locations (20)
Other
- Alberta Children's Hospital, Pediatric Epilepsy and Child Neurology - Calgary
- The Hospital of Sick Children - Toronto
- Hopital Necker- Enfants Malades - Paris
- DRK Berlin - Epilepsiezentrum und Neuropädiatrie - Berlin
- Schön Klinik Vogtareuth - Vogtareuth
- Azienda Ospedaliero-Universitaria Meyer - Florence
- Fondazione Policlinico Universitario A Gemelli, IRCCS - Roma
- Ospedale Pediatrico Bambino Gesù - Rome
- Azienda Ospedaliera Universitaria Integrata di Verona - Verona
- Hospital Infantil Universitario Niño Jesús - Madrid
- Ruber Internacional Hospital - Madrid
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- The Cleveland Clinic - Cleveland
California
- UCLA Mattel Children's Hospital - Los Angeles
Colorado
- Children's Hospital Colorado - Aurora
Georgia
- Center for Rare Neurological Diseases - Norcross
Massachusetts
- Boston Children's Hospital - Boston
New York
- New York University - New York
Pennsylvania
- Childrens Hospital of Philadlephia Division of Neurology - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2027-01-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05373719
The ClinicalTrials.gov registry entry for NCT05373719 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loulou Foundation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cyclin-Dependent Kinase-Like 5 Deficiency Disorder appearing as the primary indexed condition, and to 1 intervention - of which No intervention; observational is the first listed.
NCT05373719 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Other, Ohio, California.
Frequently Asked Questions
What is clinical trial NCT05373719 about?
NCT05373719 is a clinical study titled "Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder". Observational, noninterventional, 3-year study to examine the presence of detectable differences in neurocognitive, developmental, motor, neurophysiologic, and quality of life measures over time in patients with cyclin-dependent kinase-like 5 deficiency disorder.
What is the current status of trial NCT05373719?
This trial is currently active not recruiting. The enrollment target is 112 participants. The study started on 2022-09-30. Estimated completion is 2027-01-20.
What conditions does trial NCT05373719 study?
This clinical trial studies the following conditions: Cyclin-Dependent Kinase-Like 5 Deficiency Disorder.
What interventions are being tested in trial NCT05373719?
The interventions under investigation include: No intervention; observational (OTHER).
Who is sponsoring clinical trial NCT05373719?
This trial is sponsored by Loulou Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05373719 being conducted?
This trial has 20 study locations across California, Colorado, Georgia, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.